CROSS-SECTIONAL SURVEY TO ASSESS THE BENEFICIARIES EXPERIENCE REGARDING COVID-19 VACCINATION IN VACCINATED CANDIDATES IN A TRIBAL DISTRICT OF RAJASTHAN - EMIGH PROSPECTIVE

Authors

  • Rashmi Bhujade Department of Community Medicine, Uttar Pradesh Medical Science University, Saifai, Etawah, Inida.
  • Kanak Yadav Department of ENT, Government Medical College, Dungarpur, Rajasthan, India.
  • Jignesh Kumar Department of Pharmacology, Government Medical College, Dungarpur, Rajasthan, India.
  • Mahesh Pukar Department of Surgery, Government Medical College, Dungarpur, Rajasthan, India.
  • Ravi Bhatt Department of Community Medicine, Government Medical College, Dungarpur, Rajasthan, India.
  • Anil Singh Baghel Department of Community Medicine, Government Medical College, Dungarpur, Rajasthan, India.
  • ShashiKANT Ray Department of , National Cold Chain and Vaccine Management Resource Centre, New Delhi, India.
  • Rakesh Kumar Department of , National Cold Chain and Vaccine Management Resource Centre, New Delhi, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i6.47290

Keywords:

Experiences, Vaccinees, Vaccination procedure, Adverse event following immunization, Covid-19

Abstract

Objectives: A year with COVID-19 has been a harrowing breakneck journey. On 11th March 2020, the World Health Organization declared COVID-19 as a pandemic. It spread across globe in span of 3 months; this is how emergence of unknown virus became a multifaceted pandemic. Till date, no definitive treatment of covid-19 is available, except hope of vaccination. We must ensure safe and effective vaccination to protect people. It has been largest vaccination drive, that’s why important to know the beneficiary’s point of view regarding covid vaccination process, so that the result of this study can be used to amend the process if needed, to make the process more beneficiary friendly.

Methods: A cross-sectional study was conducted in a government covid vaccination centerto assess the beneficiaries prospective about their experience of covid-19 vaccine. The study duration was 6 months. Data were collected with the help of semi-structured pro forma.

Results: Data analysis was done with the help of SPSS-20. Approximately 93% of participants received vaccination appointment. Around 58% of participants were screened for COVID-19 symptoms. Most (90%) participants said that physical distancing was maintained during vaccination, 93% participants were informed about of vaccination process, 85% participants mentioned that staff had explained about adverse event following immunization (AEFI) before vaccination, and 76% of participants mentioned that they received Covishied, only 1 participant reported AEFI within 30 min of waiting period, and he received the preliminary treatment at vaccination center.

Conclusion: Feedback from the user is a good way to quality check; their reviews give the opportunity to improve. Most of the vaccines were satisfied with the vaccination procedure.

Downloads

Download data is not yet available.

Author Biographies

Rashmi Bhujade, Department of Community Medicine, Uttar Pradesh Medical Science University, Saifai, Etawah, Inida.

Community Medicine, Associate Professor

Kanak Yadav, Department of ENT, Government Medical College, Dungarpur, Rajasthan, India.

Department of E.N.T., Assistant Professor

Jignesh Kumar, Department of Pharmacology, Government Medical College, Dungarpur, Rajasthan, India.

Department of Pharmacology, Assistant Professor

Mahesh Pukar, Department of Surgery, Government Medical College, Dungarpur, Rajasthan, India.

Department of Surgery, Principal & Controller

Ravi Bhatt, Department of Community Medicine, Government Medical College, Dungarpur, Rajasthan, India.

Community Medicine, Statistician

ShashiKANT Ray, Department of , National Cold Chain and Vaccine Management Resource Centre, New Delhi, India.

NIHFW

Rakesh Kumar, Department of , National Cold Chain and Vaccine Management Resource Centre, New Delhi, India.

NIHFW

References

Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biol Med 2020;91:157-60. doi: 10.23750/abm.v91i1.9397, PMID 32191675, PMCID PMC7569573

World Health Organization. India Rolls out the World’s Largest COVID-19 Vaccination Drive. Geneva: WHO; 2021.

Cochran WG. Sampling Techniques. United States: John Wiley and Sons; 1977.

Mathur M, Mathur NJ. 1182 Vaccine hesitancy among health care workers: A study amidst COVID-19 vaccine drive in India. Int J Epidemol 2021;50 Suppl 1:dyab168.422.

Li AJ, Tabu C, Shendale S, Sergon K, Okoth PO, Mugoya IK, et al. Assessment of missed opportunities for vaccination in Kenyan health facilities, 2016. PLoS One 2020;15:e0237913.

Ndwandwe D, Ngcobo NJ, Adamu AA, Nnaji C, Mashunye T, Leufak AM, et al. Country-level assessment of missed opportunities for vaccination in South Africa: Protocol for multilevel analysis. JMIR Res Protoc 2020;9:e16672. doi: 10.2196/16672, PMID 32985990

Olorunsaiye CZ, Langhamer MS, Wallace AS, Watkins ML. Missed opportunities and barriers for vaccination: A descriptive analysis of private and public health facilities in four African countries. Pan Afr Med J 2017;27 Suppl 3:6.

Fatiregun AA, Lochlainn LN, Kaboré L, Dosumu M, Isere E, Olaoye I, et al. Missed opportunities for vaccination among children aged 0-23 months visiting health facilities in a southwest State of Nigeria. December 2019. PLoS One 2021;16:e0252798.

Ogbuanu IU, Li AJ, Anya BP, Tamadji M, Chirwa G, Chiwaya KW, et al. Can vaccination coverage be improved by reducing missed opportunities for vaccination? Findings from assessments in Chad and Malawi using the new WHO methodology. PLoS One 2019;14:e0210648.

Byberg S, Fisker AB, Rodrigues A, Balde I, Enemark U, Aaby P, et al. Household experience and costs of seeking measles vaccination in rural Guinea‐Bissau. Trop Med Int Health 2017;22:12-20. doi: 10.1111/tmi.12793, PMID 27717100

Parrella A, Gold M, Marshall H, Braunack-Mayer A, Watson M, Baghurst PJ. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010. Hum Vaccin Immunother 2012;8:662-7. doi: 10.4161/hv.19478, PMID 22634441

Jayadevan R, Shenoy R, Anithadevi TJ. Survey of Symptoms Following COVID-19 Vaccination in India, MedRxiv 2021.02.08.21251366; doi: https://doi.org/10.1101/2021.02.08.21251366.

Immunization WJM. Available from: https://int/immunization/ monitoring_surveillance/burden/vpd/surveillance_type/activemeasles_ monthlydata/enrsduhwwvaccinesbiol2018

Published

07-06-2023

How to Cite

Bhujade, R., K. Yadav, J. Kumar, M. Pukar, R. Bhatt, A. S. Baghel, S. Ray, and R. Kumar. “CROSS-SECTIONAL SURVEY TO ASSESS THE BENEFICIARIES EXPERIENCE REGARDING COVID-19 VACCINATION IN VACCINATED CANDIDATES IN A TRIBAL DISTRICT OF RAJASTHAN - EMIGH PROSPECTIVE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 6, June 2023, pp. 82-85, doi:10.22159/ajpcr.2023.v16i6.47290.

Issue

Section

Original Article(s)